Chris Hyland

I am an ARC Mid-Career Industry Research Fellow with the pharmacuetical company Syntara. My group is interested in developing new transition metal-catalysed reactions for the synthesis of small organic molecules with medicinal importance. We work closely with AI and computational chemistry to developed a detailed mechanistic understanding of new reaction processes. <br><br>We aim to develop tools for chemists to build complex molecules that may be used in new pharmaceuticals or materials. There is a particular focus on developing reactions that are efficient and selective so as to reduce waste and energy consumption. Through collaborations we also aim to harness synthetic chemistry to learn more about biological systems and develop potential new therapeutics. Catalysis and mechanisms of reactions, Medicinal and biomolecular chemistry, Organic chemical synthesis, Organometallic chemistry